tirzepatide rebound weight gain Trajectory of the body after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine Rebound Weight Gain After Stopping

You should also ask whether the program addresses muscle preservation

RETATRUTIDE (RETA) Third-Party Tested COA Available Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors

Epub 2016 Feb 29

doi: 10.1186/s12974-018-1370-7 126 ElderGAGama SosaMADe GasperiR

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome

A pilot human safety study with n=2 is far too small to support broad safety claims, and regulatory sources flag concerns about unapproved use, dose uncertainty, impurities, and lack of established therapeutic dosing [10][1516]